(Q36260720)

13 August 2017

1 reference

title

Aggressive multiple sclerosis-is there a role for stem cell transplantation? (English)

1 reference

13 August 2017

0 references

Eva Havrdova

1

1 reference

13 August 2017

publication date

1 September 2005

1 reference

13 August 2017

1 reference

13 August 2017

volume

252 Suppl 3

1 reference

13 August 2017

page(s)

iii34-iii37

1 reference

The use of mitoxantrone (Novantrone) for the treatment of multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

13 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00415-005-2015-1

Prevention and reversal of adoptively transferred, chronic relapsing experimental autoimmune encephalomyelitis with a single high dose cytoreductive treatment followed by syngeneic bone marrow transplantation

21 January 2018

1 reference

12 December 2020

Acute/relapsing experimental autoimmune encephalomyelitis: induction of long lasting, antigen-specific tolerance by syngeneic bone marrow transplantation.

1 reference

12 December 2020

Treatment of severe systemic lupus erythematosus with high-dose chemotherapy and haemopoietic stem-cell transplantation: a phase I study

1 reference

12 December 2020

Peripheral blood stem cell transplantation in the treatment of progressive multiple sclerosis: first results of a pilot study

1 reference

12 December 2020

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

1 reference

12 December 2020

Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group

1 reference

12 December 2020

Autologous peripheral blood stem cell transplantation in a patient with multiple sclerosis and concomitant Ph+ acute leukemia

1 reference

12 December 2020

Allogeneic bone marrow transplant for chronic myelogenous leukemia in a patient with multiple sclerosis

1 reference

12 December 2020

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group

1 reference

12 December 2020

High-dose immunosuppressive therapy with PBPC support in the treatment of poor risk multiple sclerosis.

1 reference

12 December 2020

Meta-analysis of the placebo-treated groups in clinical trials of progressive MS

1 reference

12 December 2020

Hematopoietic stem cell transplantation for multiple sclerosis: current status and future challenges

1 reference

12 December 2020

Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis. European Study Group on interferon beta-1b in secondary progressive MS

1 reference

12 December 2020

Effective treatment of relapsing experimental autoimmune encephalomyelitis with pseudoautologous bone marrow transplantation

1 reference

12 December 2020

Effect of disease stage on clinical outcome after syngeneic bone marrow transplantation for relapsing experimental autoimmune encephalomyelitis

1 reference

12 December 2020

Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study.

1 reference

12 December 2020

Treatment of autoimmune disease by intense immunosuppressive conditioning and autologous hematopoietic stem cell transplantation

1 reference

12 December 2020

Hematopoietic stem-cell transplantation for systemic lupus erythematosus

1 reference

12 December 2020

10.1007/S00415-005-2015-1

Identifiers

DOI

1 reference

13 August 2017

1 reference